Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pear Therapeutics announces first patient dosed in part II of Pear-006 feasibility study
Image: Pear Therapeutics has announced first patient dosed in part II of Pear-006 feasibility study. Photo: courtesy of Robina Weermeijer on Unsplash.
Image: Pear Therapeutics has announced first patient dosed in part II of Pear-006 feasibility study. Photo: courtesy of Robina Weermeijer on Unsplash.